DSL101

ATP7B mRNA in lipid nanoparticles · DSciLab Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DSL101, covering 2026-01-20 to 2026-01-20. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study on the Treatment of Wilson Disease With ATP7B mRNA/LNP (DSL101) [EARLY_Phase 1]